Jeffrey Fudin, B.S., Pharm.D., FCCP, FASHP
Diplomate, American Academy of Pain Management


  • Founder & Chair, PROMPT (Professionals for Rational Opioid Monitoring & Pharmacotherapy)

    Owner & Managing Editor,

    Clinical Pharmacy Specialist & Director PGY2 Pharmacy Pain Residency, Stratton VA Medical Center, Albany NY

    Adjunct Associate Professor, Western New England University College of Pharmacy

    Adjunct Assistant Professor of Pharmacy Practice, University of Connecticut School of Pharmacy

    Section Editor, Pain Medicine


Dr. Fudin graduated from Albany College of Pharmacy & Health Sciences (ACPHS) with his Bachelors Degree and his Pharm.D. He was awarded and completed an American Cancer Society Sponsored Fellowship in Oncology / Hematology at SUNY/Upstate Medical Center shortly after his undergraduate work.

He is a Diplomate to the American Academy of Pain Management, a Fellow of the American College of Clinical Pharmacy, and a member of several other professional organizations.  Dr. Fudin is a Section Editor for Pain Medicine, the official journal of the American Academy of Pain Medicine and on the Editorial Board for Practical Pain Management.  He is Founder/Chairman of Professionals for Rational Opioid Monitoring & Pharmacotherapy (PROMPT), an advocacy group in favor of safe opioid prescribing by encouraging clinician education, proactive risk stratification, and appropriate therapeutic monitoring.

Dr. Fudin was a peer reviewer established American Pain Society Clinical Practice Guidelines for Arthritis, for Fibromyalgia, and for Cancer Pain and Palliative Care. He was a panel member for establishing guidelines on the “Use of Chronic Opioids for Chronic Non-Cancer Pain”, a collaborative effort between the American Pain Society and the American Academy of Pain Medicine; these guidelines have been widely disseminated by the American Journal of Pain for use by healthcare providers worldwide. Recently, he participated in development of draft guidelines for the proper use of urine testing in addiction medicine, a collaborative project by the National Association of Addiction Treatment Providers (NAATP) with support from the Center for Lawful Access and Abuse Deterrence (CLAAD) and the American Society of Addiction Medicine (ASAM).

Dr. Fudin was named a 2010 “Parata/Pharmacy Times “Next generation Pharmacist Lifetime Achievement Honoree”.  He received the 2014 American Academy of Pain Medicine’s (AAPM) Presidential Commendation, in recognition as “a voice for scientific integrity and an advocate for people in pain.

Dr. Fudin is a reviewer for publications and poster submissions for both ACCP, ASHP, the American Academy of Pain Medicine, and other recognized professional pharmacy, medical, and nursing organizations. He is founder and tw